Exponent (EXPO) Earnings Analysis
Exponent (EXPO) next reports earnings on 2026-07-30, consensus EPS 0.55 USD. Last quarter (2026-04-30) it beat with EPS 0.59 USD vs 0.56 USD est (+5.4%). It has beaten estimates in 8/8 recent quarters (100%). Trailing P/E 28.24.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does EXPO next report earnings?
| Next earnings date | 2026-07-30 |
|---|---|
| Consensus EPS estimate | 0.55 USD |
| Revenue estimate | 0.14B |
EXPO earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-30 | 0.59 USD | 0.56 USD | +5.4% | Beat |
| 2026-02-05 | 0.49 USD | 0.47 USD | +4.3% | Beat |
| 2025-10-30 | 0.55 USD | 0.5 USD | +10% | Beat |
| 2025-07-31 | 0.52 USD | 0.48 USD | +8.3% | Beat |
| 2025-05-01 | 0.52 USD | 0.48 USD | +8.3% | Beat |
| 2025-02-06 | 0.46 USD | 0.4 USD | +15% | Beat |
| 2024-10-24 | 0.5 USD | 0.48 USD | +4.2% | Beat |
| 2024-07-25 | 0.57 USD | 0.5 USD | +14% | Beat |
Beat rate: 8/8 (100%) over reported quarters with consensus data.
EXPO valuation and analyst view
| Trailing P/E | 28.24 |
|---|---|
| Trailing EPS | 2.188 USD |
| Price / book | 8.94 |
| Dividend yield | 2.01% |
| Market cap | 2.94B |
| Analyst consensus | Buy (6 buy / 2 hold / 0 sell) |
| Avg price target | 75 USD |
Related research pages
Frequently asked questions
When is Exponent (EXPO)'s next earnings date?
Exponent is next scheduled to report on 2026-07-30, with a consensus EPS estimate of 0.55 USD and revenue estimate of 0.14B.
Did EXPO beat earnings last quarter?
In its 2026-04-30 report, EXPO posted EPS of 0.59 USD versus a 0.56 USD estimate — a beat of 5.4%.
What is EXPO's earnings track record?
Over the last 8 reported quarters with consensus data, EXPO beat estimates 8 times (100%).
What is EXPO's current P/E ratio and EPS?
EXPO trades at a trailing P/E of 28.24 on trailing EPS of 2.187748543884314 USD.
What do analysts rate EXPO?
Analyst consensus is "Buy" across 8 ratings (0 strong buy, 6 buy, 2 hold, 0 sell, 0 strong sell). Average 12-month price target: 75 USD.